<SEC-DOCUMENT>0001213900-25-004060-index.html : 20250116 <SEC-HEADER>0001213900-25-004060.hdr.sgml : 20250116 <ACCEPTANCE-DATETIME>20250116104028 ACCESSION NUMBER: 0001213900-25-004060 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250116 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: KAZIA THERAPEUTICS LTD CENTRAL INDEX KEY: 0001075880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: C3 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-50612 FILM NUMBER: 25534633 BUSINESS ADDRESS: STREET 1: THREE INTERNATIONAL TOWERS LEVEL 24, STREET 2: 300 BARANGAROO AVENUE CITY: SYDNEY NSW STATE: C3 ZIP: 2000 BUSINESS PHONE: 01161298780088 MAIL ADDRESS: STREET 1: THREE INTERNATIONAL TOWERS LEVEL 24, STREET 2: 300 BARANGAROO AVENUE CITY: SYDNEY NSW STATE: C3 ZIP: 2000 FORMER COMPANY: FORMER CONFORMED NAME: NOVOGEN LTD DATE OF NAME CHANGE: 19981228 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Alumni Capital LP CENTRAL INDEX KEY: 0001912606 ORGANIZATION NAME: IRS NUMBER: 873893017 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 405 LEXINGTON AVE. STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 BUSINESS PHONE: (818) 438-9794 MAIL ADDRESS: STREET 1: 405 LEXINGTON AVE. STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-1 <SEQUENCE>2 <FILENAME>ea022788001ex-1_kazia.htm <DESCRIPTION>AGREEMENT OF JOINT FILING <TEXT> Document 2 - file: ea022788001ex-1_kazia.htm
</DOCUMENT> </SEC-DOCUMENT>